Oseltamivir Improved Thrombocytopenia During Veno-Arterial Extracorporeal Membrane Oxygenation in Adults With Refractory Cardiac Failure: A Single-Center Retrospective Real-World Study
- 1Department of Critical Care Medicine, Qilu Hospital, Cheeloo College of Medicine, Shandong University, Jinan, China
- 2Department of Hematology, Qilu Hospital, Cheeloo College of Medicine, Shandong University, Jinan, China
- 3Department of Emergency, Qilu Hospital, Cheeloo College of Medicine, Shandong University, Jinan, China
by Li, Y., Wang, L., Zhang, J., Han, H., Liu, H., Li, C., Guo, H., Chen, Y., and Chen, X. (2021). Front Cardiovasc Med. 8:645867. doi: 10.3389/fcvm.2021.645867
In the published article, there was an error in the affiliations. Instead of Qilu Hospital, Shandong University, Jinan, China, it should be:
1 Department of Critical Care Medicine, Qilu Hospital, Cheeloo College of Medicine, Shandong University, Jinan, China
2 Department of Hematology, Qilu Hospital, Cheeloo College of Medicine, Shandong University, Jinan, China
3 Department of Emergency, Qilu Hospital, Cheeloo College of Medicine, Shandong University, Jinan, China.
YL is affiliated with 1, LW is affiliated with 2, JZ is affiliated with 1, HH is affiliated with 1, HL is affiliated with 1, CL is affiliated with 2, HG is affiliated with 1, YC is affiliated with 3, XC is affiliated with 1.
Furthermore, Lin Wang was not included as a co-first author in the published article. This has been corrected, and a new statement has been added to indicate that Yuan Li and Lin Wang contributed equally: “These authors contributed equally to this work.”
The authors apologize for these errors and state that this does not change the scientific conclusions of the article in any way. The original article has been updated.
Publisher's Note
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.
Keywords: extracorporeal membrane oxygenation, veno-arterial, thrombocytopenia, platelets, cardiac failure, oseltamivir, desialylation
Citation: Li Y, Wang L, Zhang J, Han H, Liu H, Li C, Guo H, Chen Y and Chen X (2021) Corrigendum: Oseltamivir Improved Thrombocytopenia During Veno-Arterial Extracorporeal Membrane Oxygenation in Adults With Refractory Cardiac Failure: A Single-Center Retrospective Real-World Study. Front. Cardiovasc. Med. 8:784904. doi: 10.3389/fcvm.2021.784904
Received: 28 September 2021; Accepted: 11 October 2021;
Published: 29 October 2021.
Approved by:
Frontiers Editorial Office, Frontiers Media SA, SwitzerlandCopyright © 2021 Li, Wang, Zhang, Han, Liu, Li, Guo, Chen and Chen. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
*Correspondence: Xiaomei Chen, Y2hlbnhtMDA4QDE2My5jb20=
†These authors have contributed equally to this work